Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Share this article:
Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Sponsor and Collaborators

Therapeutic Advances in Childhood Leukemia Consortium
Enzon Pharmaceuticals, Inc.

Contact
Contact: Jeannette van der Giessen, BA
323-361-8725
jvandergiessen@chla.usc.edu

Contact: Elena Eckroth
323-361-5429
eeckroth@chla.usc.edu

Principal Investigator
Study Chair: Elizabeth Raetz, MD New York University Medical Center
Study Chair: William Carroll, MD New York University Medical Center

ClinicalTrials.gov Identifier
NCT01186328
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs